Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

By sjmartinez • April 8, 2023

Piccari L, Allwood B, Antoniou K, Chung JH, Hassoun PM, Nikkho SM, Saggar R, Shlobin OA, Vitulo P, Nathan SD, Wort SJ. Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension. Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. PMID: 37025209; PMCID: PMC10071306.

Tags: endophenotype, histology, idiopathic pulmonary fibrosis, pathophysiology, Publications, pulmonary vascular disease, Pulmonary, Critical Care & Sleep Medicine

Managing a Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Holocord With Intravenous Antibiotics

Dao KT, Perera MX, Yip SA, Fox K. Managing a Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Holocord With Intravenous Antibiotics. Cureus. 2025 Mar 2;17(3):e79918.[...]

Injectable Estradiol Dosing Regimens in Transgender and Nonbinary Adults Listed as Male at Birth

Kanin M, Slack M, Patel R, Chen KT, Jackson N, Williams KC, Grock S. Injectable Estradiol Dosing Regimens in Transgender and Nonbinary Adults Listed as[...]

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]